Assessing cardiac safety in oncology drug development

Am Heart J. 2019 Aug:214:125-133. doi: 10.1016/j.ahj.2019.04.010. Epub 2019 May 4.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects
  • Biomarkers / blood
  • Cardiologists
  • Cardiovascular Diseases / chemically induced*
  • Cell Line, Tumor
  • Clinical Trials as Topic
  • Data Collection
  • Drug Development*
  • Drug Screening Assays, Antitumor
  • Heart / drug effects*
  • Humans
  • Immunotherapy / adverse effects
  • Medical Oncology
  • Research Design
  • Trastuzumab / adverse effects

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Immunological
  • Biomarkers
  • Trastuzumab